Recent events
Recent events tied to this brand in public sources.
Back to profile1 entries
2021
CMA fines Advanz over thyroid tablet pricing
The UK Competition and Markets Authority imposed fines of more than £100 million on Advanz and its former private equity owners after finding that Advanz charged excessive and unfair prices for liothyronine tablets.